Monitor for subsequent Form 4 filings or amended disclosures that may reveal actual share holdings, purchases, or sales. Absent specific ownership data, this filing does not indicate insider buying or selling activity.
Price Chart
Executive Summary
John P. Schmid filed a Form 3 disclosing initial beneficial ownership of securities in First Tracks Biotherapeutics, Inc. (TRAX). This is a routine regulatory filing required when an individual becomes a director, officer, or 10% owner of a company, and no specific holdings or transactions are disclosed in the available documents.
Key Facts
- Form 3 filed by John P. Schmid for First Tracks Biotherapeutics, Inc. (TRAX)
- Filing date: April 1, 2026
- No specific share amounts, ownership percentages, or transaction details are included in the provided documents
- This is an initial statement of beneficial ownership, typically filed upon becoming an insider
- Company previously known as Biopharma Company, Inc. (name changed October 10, 2025)
Financial Impact
No financial impact disclosed — no share quantities or values reported
Risk Factors
- Lack of disclosed ownership details limits ability to assess insider sentiment
- Potential for future disclosures to reveal material ownership if Schmid holds or acquires a significant stake
Investment Themes
Documents Analyzed
This report is based on 3 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 3 Filing (Primary) | 0001478916-26-000003 |
| Document: 0001478916-26-000003-index.html | 0001478916-26-000003 |
| Document: 0001478916-26-000003.txt | 0001478916-26-000003 |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Oct 26, 2026 today | S-1 | $43.80 | awaiting T+1 | — | $44.05 (+0.57%) |
Oct 20, 2026 5d ago | 8-K | $42.77 $43.14 | ▲ +0.87% | ▲ +2.05% | $44.05 (+2.99%) |
Oct 15, 2026 10d ago | 8-K | $34.46 $36.28 | ▼ −5.28% | ▼ −4.86% | $44.05 (−27.83%) |
Oct 15, 2026 11d ago | Press Release | $36.04 $34.46 | ▲ +4.38% | ▲ +3.28% | $44.05 (−22.23%) |
Oct 13, 2026 13d ago | 8-K | $31.68 $34.13 | ▲ +7.73% | ▲ +8.81% | $44.05 (+39.05%) |
Aug 12, 2026 10w ago | 8-K | $44.03 $44.04 | ▲ +0.02% | ▲ +0.22% | $44.05 (+0.05%) |
Aug 12, 2026 10w ago | Press Release | $44.03 $44.04 | ▲ +0.02% | ▲ +0.22% | $44.05 (+0.05%) |
Aug 7, 2026 11w ago | 3/A | $47.92 $46.75 | ▼ −2.44% | ▼ −2.12% | $44.05 (−8.08%) |
Jun 22, 2026 17w ago | 8-K | $17.78 $16.69 | ▼ −6.13% | ▼ −6.08% | $44.05 (+147.75%) |
May 14, 2026 23w ago | 8-K | $16.90 $17.79 | ▲ +5.27% | ▲ +5.33% | $44.05 (+160.65%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers